For research use only. Not for therapeutic Use.
KSI-3716 (Cat.No:I020007) is a small molecule inhibitor that targets the enzyme 3-ketosteroid Δ^1-dehydrogenase (KSI), which is involved in the biosynthesis of androgens and estrogens. By inhibiting KSI, KSI-3716 disrupts steroid hormone synthesis, making it a potential therapeutic option for hormone-dependent cancers such as breast and prostate cancer. Further research is ongoing to explore its efficacy and safety profile.
Catalog Number | I020007 |
CAS Number | 1151813-61-4 |
Molecular Formula | C₁₇H₁₁BrCl₂N₂O₂ |
Purity | ≥95% |
Target | Autophagy |
Reference | [1]. Jeong KC, et al. Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth. J Urol. 2014 Feb;191(2):510-8. |